ERBB2 and breast carcinoma: Breast cancers can be subdivided in three groups upon biological features and associated therapies: tumors expressing estrogen (ER) and/or progesterone (PR) receptors, tumors overexpressing ERBB2, and triple negative (TN) tumors that lack ER, PR and express no or normal ERBB2 levels [1].